- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$25.9b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$186.84
7D
-6.6%
1Y
32.1%
BioNTech
Market Cap: US$20.6b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$85.25
7D
-3.6%
1Y
-6.4%
Sam Chun Dang Pharm
Market Cap: ₩27.5t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩1,184,000.00
7D
25.8%
1Y
617.6%
Illumina
Market Cap: US$18.0b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$120.81
7D
-2.4%
1Y
52.3%
Regencell Bioscience Holdings
Market Cap: US$12.7b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$23.33
7D
-7.5%
1Y
2,680.9%
Elanco Animal Health
Market Cap: US$11.5b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.44
7D
-4.1%
1Y
123.2%